Table 7 Multivariate models of risk factors for 30-day crude mortality in patients with carbapenem-resistant K.pneumoniae bacteremia
HR (95% CI) | p | |
|---|---|---|
Model1 | ||
• Initial adequate therapy | 0.08 (0.01 to 0.72) | 0.02 |
• Pt not identified as CRKP carrier at onset | Not included in the model | |
• Neutrophil recovery (>1000/mmc) within 72 h from the onset of bacteremia | Not included in the model | |
Model2 | ||
• Initial adequate therapy | 0.08 (0.01 to 0.72) | 0.02 |
• Breakthrough bacteremia occurrence within 48 h of ongoing antibiotics | 0.17 (0.01 to 2.58) | 0.20 |
• Intensive Chemotherapy | 10.9 (0.73 to 162.8) | 0.08 |
• AML | Not included in the model | |
Model3 | ||
• Initial adequate therapy | 0.05 (0.002 to 0.86) | 0.04 |
• Breakthrough bacteremia occurrence within 48 h of ongoing antibiotics | 0.17 (0.01 to 2.58) | 0.20 |
• Intensive Chemotherapy | 10.9 (0.73 to 162.8) | 0.08 |
• Pt not identified as CRKP carrier at onset | Not included in the model | |
• Neutrophil recovery (>1000/mmc) within 72 h from the onset of bacteremia | Not included in the model | |
• AML | Not included in the model | |